Wird geladen...
Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
Amyloid-β (Aβ) and tau proteins currently represent the two most promising targets to treat Alzheimer's disease. The most extensively developed method to treat the pathologic forms of these proteins is through the administration of exogenous antibodies, or passive immunotherapy. In this review,...
Gespeichert in:
| Veröffentlicht in: | Neurobiol Dis |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Authors. Published by Elsevier Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7365083/ https://ncbi.nlm.nih.gov/pubmed/32682954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2020.105010 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|